1-4 of 4
David A Fox
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A CD6-Targeted Antibody-Drug Conjugate As a Potential Therapy for T Cell-Mediated Disorders

Linjun Zhang, Liping Luo, Joel Chen, Rupesh Singh, William Baldwin, David A Fox, Daniel Lindner, Feng Lin
Journal: Blood
Blood (2021) 138 (Supplement 1): 3817.
https://doi.org/10.1182/blood-2021-145449
Published: 2021
Journal Articles

CD6-Targeted Antibody-Drug Conjugate As a Potential Therapeutic Agent for T Cell Lymphomas

Neetha Parameswaran, Liping Luo, Lingjun Zhang, Joel Chen, David A Fox, Eric D. Hsi, Deepa Jagadeesh, Feng Lin
Journal: Blood
Blood (2021) 138 (Supplement 1): 1193.
https://doi.org/10.1182/blood-2021-146855
Published: 2021
Journal Articles

Plasma CXCL9 elevations correlate with chronic GVHD diagnosis

Carrie L. Kitko, John E. Levine, Barry E. Storer, Xiaoyu Chai, David A. Fox, Thomas M. Braun, Daniel R. Couriel, Paul J. Martin, Mary E. Flowers, John A. Hansen, Lawrence Chang, Megan Conlon, Bryan J. Fiema, Rachel Morgan, Prae Pongtornpipat, Kelly Lamiman, James L. M. Ferrara, Stephanie J. Lee, Sophie Paczesny
Journal: Blood
Blood (2014) 123 (5): 786–793.
https://doi.org/10.1182/blood-2013-08-520072
Published: 2014
Includes: Supplemental data
Journal Articles

The functional interactions between CD98, β1-integrins, and CD147 in the induction of U937 homotypic aggregation

Jae Youl Cho, David A. Fox, Vaclav Horejsi, Kimitaka Sagawa, Keith M. Skubitz, David R. Katz, Benjamin Chain
Journal: Blood
Blood (2001) 98 (2): 374–382.
https://doi.org/10.1182/blood.V98.2.374
Published: 2001